Skip to main content
Fig. 3 | BMC Cancer

Fig. 3

From: Interferon-beta enhances sensitivity to gemcitabine in pancreatic cancer

Fig. 3

Cell cycle analysis. Cell cycle distribution in BxPC-3 (left panel), CFPAC-1 (middle panel), and Panc-1 (right panel) after 72 h IFN-β, 72 h gemcitabine, and after 72 h IFN-β pre-treatment followed by 72 h gemcitabine monotherapy. Used concentrations IFN-β: 100 IU/ml for BxPC-3 and CFPAC-1, and 1000 IU/ml for Panc-1. Used concentrations gemcitabine: 1 ng/ml for CFPAC-1 and 2.5 ng/ml for BxPC-3 and Panc-1. Values represent mean ± SEM of at least two independent experiments and are shown as relative percentage of the total cell population. *p < 0.05, **p < 0.01, and ***p < 0.001 versus control

Back to article page